Bayer is potentially facing thousands of Trasylol lawsuits brought on behalf of individuals and families of heart surgery patients throughout the United States. Trasylol also referred to as “Aprotinin” is a bovine pancreatic trypsin inhibitor (BPTI). Trasylol is used during heart surgery to help prevent excessive bleeding.
In November 2007, the Food and Drug Administration requested that Bayer stop marketing Trasylol until further review of a Canadian study that revealed the heart surgery drug increased the risk of death. From the FDA website:
The FDA requested the suspension in the interest of patient safety based on the serious nature of the outcomes suggested in the preliminary data. FDA has not yet received full study data but expects to act quickly with Bayer, the study’s researchers at the Ottawa Health Research Institute, and other regulatory agencies to undertake a thorough analysis of data to better understand the risks and benefits of Trasylol.
An important study published in the New England Journal of Medicine in January 2006 linked Trasylol with kidney damage compared to less expensive generic medications aminocaproic acid and tranexamic acid. It is estimated that if Trasylol had been taken off the market in early 2006 following the study, 22,000 patient lives could have been saved.
For more information regarding a Trasylol lawsuit please call Fields Law Firm or e-mail us for a free confidential consultation. We are presently representing patients and families throughout the United States.
We are a Law Firm that is dedicated to helping people who have been affected by Trasylol side effects.
Personal Injury Law Firm
Bayer HealthCare Pharmaceuticals, Inc. has been facing an increasing number of patients who have filed a Trasylol lawsuit over its Aprotinin heart surgery drug. The lawsuits allege that Bayer is liable for manufacturing and failing to warn Trasylol users of its dangerous side effects. The Trasylol lawsuits allege that Bayer knew Trasylol increases patients’ risk [...]
Until recently, Bayer’s anti-bleeding drug was used on a regular basis during heart surgery. Trasylol (Aprotinin) is widely used to decrease bleeding risk during coronary artery bypass graft (CABG) surgery. There are some common side effects that persist or become bothersome following use, including: constipation, diarrhea, difficulty urinating, infection (fever, chills, sore throat), lightheadedness, sleeplessness [...]
We represent all Trasylol lawsuits clients on a contingency basis which means that there are never any legal fees unless we win compensation in your case. For a free no-obligation consultation please call toll free at 1-888-343-5375 or fill out our short online contact form and a Trasylol lawyer will contact you to answer any of [...]
Trasylol Aprotinin Side Effects Study
Another study reveals an increased risk of serious Trasylol side effects leading to a higher mortality rate in aprotinin bypass patients. A recent study published in The New England Journal of Medicine on February 21, 2008 shows an increased risk of death for patients receiving aprotinin (Trasylol) during coronary-artery bypass grafting [...]
Trasylol Heart Surgery Drug Information
What is aprotinin injection?
APROTININ (Trasylol) is a drug that affects the way blood clots. It was given to heart surgery patients during bypass procedures. Aprotinin was mainly used during repeat coronary artery bypass surgery to reduce the amount of bleeding before and after surgery. Trasylol and other clotting medications help to [...]